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LETTER TO THE EDITOR
Nosocomial enterococcal infection
in neonates
Enterococcus spp. is the third most common
cause of nosocomial infection in adults and the
fourth most common in children.1,2 All enterococ-
cal infections from 1999–2000 among 246 neonates
hospitalized in the neonatal intensive care unit in
the neonatal referral centre were investigated.
Univariate analysis to assess risk factors for neona-
tal infections caused by Enterococcus spp. (99) vs.
those caused by other organisms (147) was per-
formed (Epi Info 2.1). In 99 cases Enterococcus
spp. was isolated from various samples, in 15 cases
from blood cultures (bacteremia) (P ≤ 0.001), in
six cases from catheter tips, in 82 cases from throat
swabs (P ≤ 0.04) and in 20 cases from skin swabs
(omphalitis) (P ≤ 0.01) (Table 1).
The early markers of enterococcal infections as
compared to other infection were higher procalci-
tonin levels (P ≤ 0.004) and positive septic score
Table 1 Comparison of neonates infected with Enterococcus spp. vs. without Enterococcus spp.
Total Neonates infected
with Enterococcus
spp. (%)
Neonates infected
without Enterococcus
spp. (%)
P
No. of newborn infants 246 99 147
1. Risk factors
Gestational age
<28 weeks 8 2 (2%) 6 (4%) NS
28–32 weeks 41 22 (22%) 19 (13%) NS
32–38 weeks 126 50 (51%) 76 (52%) NS
>38 weeks 71 25 (25%) 46 (31%) NS
Birth weight
<1000 g 8 3 (3%) 5 (3%) NS
1000–1500 g 28 15 (15%) 13 (9%) NS
1500–2500 g 104 44 (44%) 60 (41%) NS
>2500 g 106 37 (37%) 69 (47%) NS
Other risk factors
Umbilical catheters 112 56 (57%) 56 (38%) 0.006
Ventilator support 37 20 (20%) 17 (12%) NS
Corticosteroid therapy 11 6 (6%) 5 (3%) NS
Total parenteral nutrition 30 15 (15%) 15 (10%) NS
Respiratory distress syndrome 11 3 (3%) 8 (5%) NS
Mother’s risk factors
Prolonged rupture of membranes 21 10 (10%) 11 (7%) NS
Fever 21 10 (10%) 11 (7%) NS
Colonization 29 12 (12%) 17 (12%) NS
(P ≤ 0.02). Bacteremia was signiﬁcantly more
frequently observed among neonates with entero-
coccal infections than among neonates with other
infections (P ≤ 0.005). Only 44 cases were due only
to Enterococcus spp. Viridans streptococci (51.5%
vs. 37.4%, P ≤ 0.04) and non-albicans Candida spp.
(25.2% vs. 13.6, P ≤ 0.03) as co-pathogens were
signiﬁcantly more frequently observed in neonatal
infections caused by Enterococcus spp. Outcome
(both attributable and overall mortality) was sim-
ilar to other infections. However, neurological
sequelae, such as intraventricular haemorrhage
(grade III/IV) (P ≤ 0.02), was signiﬁcantly more
frequently observed in cases with enterococcal in-
fections than in neonates with other infections.
Overall and attributable mortality were both very
low (2.0%) which is in contrast to adults in whom
mortality from enterococcal infections exceeds
15%.3 However, since only 44 cases were due to
Enterococcus spp. alone, their precise role remains
uncertain (Table 1).
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Table 1 (Continued ).
Total Neonates infected
with Enterococcus
spp. (%)
Neonates infected
without Enterococcus
spp. (%)
P
Cerclage 16 6 (6%) 10 (7%) NS
Abortion 39 19 (19%) 20 (14%) NS
Nicotine abuse 11 4 (4%) 7 (5%) NS
Origin isolates
Blood cultures 20 15 (15%) 5 (3%) 0.001
Positive catheter tips 11 6 (6%) 5 (3%) NS
Nasal swabs 178 83 (84%) 95 (65%) 0.001
Throat swabs 186 82 (83%) 104 (71%) 0.04
Skin swabs 32 20 (20%) 12 (8%) 0.01
Etiology
Staphylococcus aureus 121 55 (56%) 66 (45%) NS
Staphylococcus epidermidis 148 65 (66%) 83 (56%) NS
Streptococcus agalactiae 18 6 (6%) 12 (8%) NS
Viridans streptococci 106 51 (52%) 55 (37%) 0.04
Acinetobacter baumannii 4 1 (1%) 3 (2%) NS
Citrobacter freundii 6 3 (3%) 3 (2%) NS
Escherichia coli 69 27 (27%) 42 (29%) NS
Klebsiella/Enterobacter spp. 111 47 (47%) 64 (44%) NS
Listeria spp. 3 1 (1%) 2 (1%) NS
Moraxella catharrhalis 1 1 (1%) 0 (0%) NS
Proteus spp. 5 2 (2%) 3 (2%) NS
Stenotrophomonas maltophilia 32 15 (15%) 17 (12%) NS
Candida albicans 2 0 (0%) 2 (1%) NS
Non-albicans Candida spp 45 25 (25%) 20 (14%) 0.03
Haemophilus inﬂuenzae 4 0 (0%) 4 (3%) NS
Others 2 0 (0%) 2 (1%) NS
2. Diagnostic indicators
C-reactive protein >10mg/ml 117 52 (53%) 65 (44%) NS
Procalcitonin >0.5 ng/mm3 17 13 (13%) 4 (3%) 0.004
Thrombocytes <50,000/mm3 17 10 (10%) 7 (5%) NS
Leukocytesa 9 5 (5%) 4 (3%) NS
Septic score >2 points 19 13 (13%) 6 (4%) 0.02
3. Localization of infection site
Bacteremia 25 17 (17%) 8 (5%) 0.005
Meningitis 3 2 (2%) 1 (1%) NS
Pneumonia 91 38 (38%) 53 (36%) NS
Conjunctivitis 47 14 (14%) 33 (22%) NS
Thrush stomatitis 34 16 (16%) 18 (12%) NS
Omphalitis 23 6 (6%) 17 (12%) NS
Others 30 14 (14%) 16 (11%) NS
4. Outcome
Cure 239 97 (98%) 142 (97%) NS
Death on infection 4 2 (2%) 2 (1%) NS
Death on underlying disease 3 0 (0%) 3 (2%) NS
Periventricular leukomalacia 2 0 (0%) 2 (1%) NS
Intraventricular haemorrhage (III/IV) 7 6 (6%) 1 (1%) 0.02
Septic score deﬁnition: Sepsis score is positive if the points sum to more than 2. The parts of the sepsis score
are: clinical symptoms of infection (from at least two organ systems) — 1 point; positive leukocyte indexes —
2 points; positive C-reactive protein — 1 point; positive one of three parameters: IgM, ESR or thrombocytes —
1 point. Clinical symptoms: General symptoms — instability of body temperature, apathy, child’s appearance,
hypoglycemia or hyperglycemia. Respiratory system — dyspnea, tachypnea, apnea interval, increased need for
oxygen. Cardiovascular system — tachycardia, bradycardia, hypotension, hypertension. Gastrointestinal tract —
sickness, diarrhoea, intolerant of food. Central nervous system — hypotonia, hypertonia, spasms.
a Leukocyte indexes: Total number of leukocytes in ﬁrst 48 hours of life: <10,000 or >25—30,000 cells/mm3 Total
number of leukocytes after the ﬁrst 48 hours of life: <5000 or >20,000 cells/mm3 Positive C-reactive protein: Level
elevated >10mg/mL Positive parameters: IgM >0.2 g/l; ESR (100mm3 of blood) >15mm/1hour; Thrombocyte
count <50,000 cells/mm3.
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